Advertisement

Merrimack Pharmaceuticals, Inc. MACK

Set alert

Price alert · MACK

All alert types
15.15 +15.15 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
223.75M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
100.00%
More statistics
Low
—
High
—
Forward P/E
-8.50
Beta
1.42
Short ratio
8.65
Inst. own
62.98%
Dividend
15.10
Ex-div date
May 8, 2024
Earnings
May 15, 2024
50-d avg
14.84
200-d avg
13.48
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MACK has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $161.00KExpenses → Selling, General & Admin: $16.96MExpenses → Research & Development: $37.76MExpenses → Interest Expense: $4.48MGross Profit → Expenses: $16.44MRevenue → Gross Profit: $16.44MNet Loss → Expenses: $42.59MOther Income$161.00KGross Profit$16.44MNet Loss$42.59MExpenses$59.20MSelling, General & Admin$16.96MResearch & Development$37.76MInterest Expense$4.48MRevenue$16.44M

Period ending Mar 31, 2024 · select a line to chart its history

Income statement

MACK quarterly income statement
669.00K
669.00K
-669.00K
201.37M
201.37M
201.37M
201.37M
-201.81M
13.93
13.93
13.93
201.37M
201.37M
14.45M
14.45M

Balance sheet

MACK quarterly balance sheet
234.16M
234.16M
9.95M
9.95M
244.32M
244.32M
22.67M
22.67M
-347.45M
221.65M
221.65M
3.00K
566.00K
22.11M

Cash flow

MACK quarterly cash flow
1.49M
228.17M
225.00M
1.49M
228.00M
3.00M
-1.31M
48.00K
Advertisement